Supplements

What the Research Actually Says About What Is Fish Oil Used for

Fish oil is one of the best-selling supplements on the planet, yet most people taking it have only a vague idea of what it's actually doing inside their bodies. The clinical picture is more nuanced — and more impressive — than the label ever tells you. Here's what the peer-reviewed science actually says.

Jared Murray ·Co-Founder & Head of Health Research, Ones · ·9 min read
fish oilomega-3EPA DHAsupplementsheart healthinflammation
What the Research Actually Says About What Is Fish Oil Used for

What the Research Actually Says About What Is Fish Oil Used for

Fish oil is the world's most purchased single-ingredient supplement, generating over $2 billion in annual U.S. sales. Yet survey data consistently show that a large portion of users couldn't explain the mechanism behind it beyond "it's good for your heart." That's a problem — because understanding why fish oil works, for whom, at what dose, and when to take it is the difference between supplementing strategically and just swallowing expensive placebo.

This article breaks down the real clinical evidence: what fish oil's active compounds are, what conditions the research actually supports, where the evidence is weaker than the marketing suggests, and how to integrate it into a precision nutrition protocol.

---

Fish Oil Uses: What the Active Compounds Actually Do

Fish oil's biological activity comes almost entirely from two long-chain omega-3 polyunsaturated fatty acids: eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). These are not interchangeable with the short-chain ALA found in flaxseed — the human conversion rate from ALA to EPA is approximately 5–10%, and from ALA to DHA is below 1% (Burdge & Calder, Proceedings of the Nutrition Society 2005; PMID: 16188209).

EPA and DHA work through several overlapping mechanisms:

  • Membrane fluidity: DHA is a structural component of cell membranes, particularly in the brain and retina, where it modulates receptor function and signal transduction.
  • Eicosanoid precursors: EPA competes with arachidonic acid (AA) for cyclooxygenase and lipoxygenase enzymes, reducing the synthesis of pro-inflammatory prostaglandins and leukotrienes.
  • Specialized pro-resolving mediators (SPMs): Both EPA and DHA are precursors to resolvins, protectins, and maresins — signaling molecules that actively resolve inflammation rather than simply suppressing it (Serhan et al., Nature Reviews Immunology 2014; PMID: 25234142).
  • Gene expression: Omega-3s activate PPAR-alpha and PPAR-gamma nuclear receptors, modulating genes involved in lipid metabolism, inflammation, and glucose homeostasis.

This multi-pathway activity explains why the research on fish oil spans so many different health domains.

---

Cardiovascular Health: Where the Evidence Is Strongest — and Most Debated

The cardiovascular case for fish oil is both the most studied and the most contentious area of the literature.

On the lipid side, the evidence is clear: fish oil reliably reduces serum triglycerides. A meta-analysis of 21 randomized controlled trials found that omega-3 supplementation reduced triglycerides by an average of 25–30% in hypertriglyceridemic patients, with dose-dependent effects observed at 2–4 g/day of EPA+DHA (Harris et al., American Journal of Cardiology 2007; PMID: 17307293). The FDA has approved high-dose prescription omega-3 formulations (Vascepa, Lovaza) specifically for severe hypertriglyceridemia on the basis of this evidence.

The question of whether fish oil reduces hard cardiovascular events (heart attack, stroke, cardiovascular death) is more complex. The ASCEND trial (n=15,480 diabetic patients) found a modest 11% reduction in serious vascular events with 1 g/day omega-3 (ASCEND Study Collaborative Group, NEJM 2018; PMID: 30146932). The landmark REDUCE-IT trial, using 4 g/day of purified EPA (icosapentaenoic acid) in statin-treated patients with elevated triglycerides, found a 25% reduction in major cardiovascular events (Bhatt et al., NEJM 2019; PMID: 30145935). However, critics noted that the mineral oil placebo used in REDUCE-IT may have inflated the apparent benefit.

The STRENGTH trial, using a 4 g/day EPA+DHA combination with a corn oil placebo, found no cardiovascular benefit (Nicholls et al., JAMA 2020; PMID: 33190147). The ongoing debate suggests that EPA-only formulations and dose (≥3 g/day) may matter significantly — a nuance absent from standard supplement label dosing of 1 g.

---

Brain Health and Cognitive Function

DHA comprises approximately 30–40% of the fatty acids in the brain's gray matter, making it structurally indispensable. Low DHA status has been associated with accelerated cognitive decline, depression, and elevated dementia risk (Yurko-Mauro et al., Alzheimer's & Dementia 2010; PMID: 20434951).

For depression specifically, a meta-analysis of 35 RCTs found that omega-3 supplementation, particularly formulations with a higher EPA:DHA ratio (≥60% EPA), produced significant antidepressant effects (Liao et al., Translational Psychiatry 2019; PMID: 31383846). The mechanism appears to involve EPA's modulation of inflammatory cytokines and serotonin transporter expression.

For cognitive aging, a 2010 double-blind RCT (n=485) found that 900 mg/day of DHA for 24 weeks significantly improved memory and learning in healthy older adults with mild memory complaints (Yurko-Mauro et al., PMID: 20434951 cited above). This is among the most rigorous cognitive trials for a non-prescription intervention.

If you're also interested in optimal magnesium glycinate dosage for sleep and brain recovery, the combination of DHA with magnesium glycinate is worth noting: both support synaptic plasticity through complementary mechanisms.

---

Joint, Inflammatory, and Immune Health

Rheumatoid arthritis (RA) represents one of the most replicated applications of fish oil. A meta-analysis of 17 RCTs found that omega-3 supplementation significantly reduced joint pain intensity, morning stiffness, and NSAID use in RA patients (Goldberg & Katz, Pain 2007; PMID: 17335973). Doses in effective trials ranged from 2.7 to 9 g/day EPA+DHA, with effects typically emerging after 12 weeks of consistent use.

Beyond RA, omega-3s have demonstrated anti-inflammatory effects in inflammatory bowel disease, psoriasis, and exercise-induced muscle damage. A 2011 RCT found that 6 weeks of EPA+DHA supplementation (3 g/day) attenuated delayed-onset muscle soreness and reduced inflammatory markers (IL-6, TNF-alpha) following eccentric exercise (Smith et al., Clinical Journal of Sport Medicine 2011; PMID: 21116018).

---

What Is Magnesium Glycinate Used for — and How It Pairs with Fish Oil

While fish oil occupies a different mechanistic category, one supplement that frequently appears alongside omega-3s in precision protocols is magnesium glycinate. What is magnesium glycinate used for often comes down to the same overlapping goals: reducing systemic inflammation, improving sleep quality, and supporting cardiovascular and neuromuscular function.

Magnesium deficiency — which affects an estimated 45–68% of Americans based on dietary intake data (Rosanoff et al., Nutrition Reviews 2012; PMID: 22364157) — impairs the delta-6-desaturase enzyme responsible for converting dietary precursors into EPA and DHA. This means suboptimal magnesium status can blunt your omega-3 metabolism even if you're taking fish oil daily. Magnesium glycinate, specifically, has superior bioavailability and GI tolerability compared to magnesium oxide, making it the preferred clinical form when repletion is the goal.

Ones formulas include Magnesium Complex as a System Blend — combining magnesium glycinate with other well-absorbed forms, dosed within the therapeutic range supported by clinical research — making it easy to address both deficiencies in a single personalized protocol.

---

Best Time to Take Omega-3 Fish Oil

Timing matters more than most people realize. The bioavailability of EPA and DHA is significantly improved when fish oil is taken with a fat-containing meal. A pharmacokinetic study found that taking omega-3 ethyl esters with a high-fat meal increased absorption by approximately 73% compared to fasting conditions (Lawson & Hughes, The American Journal of Clinical Nutrition 1988; PMID: 3354483). While this study predates 2010, it remains a foundational pharmacokinetic reference.

For re-esterified triglyceride (rTG) forms of fish oil, which Ones sources, absorption is superior to ethyl ester forms even without a high-fat meal, though co-ingestion with food still enhances uptake.

Practical recommendations:

  1. Take with your largest meal of the day — typically lunch or dinner, which naturally contains fat from protein sources.
  2. Avoid taking on an empty stomach — this is the most common cause of the "fish burp" side effect and reduces bioavailability simultaneously.
  3. Split doses for high-dose protocols — if taking ≥2 g/day, splitting into two doses (morning and evening meals) can improve tolerability and maintain steadier plasma levels.
  4. Consistency over timing precision — a 12-week minimum is needed for meaningful changes in red blood cell membrane EPA+DHA composition (the Omega-3 Index); daily consistency matters more than the exact meal time.

For athletes or individuals interested in what is creatine monohydrate used for, it's worth noting that both omega-3s and creatine can be taken with the same meal — there is no known negative interaction, and both benefit from co-ingestion with carbohydrates or protein.

---

What Is Creatine Monohydrate Used for — and Where It Diverges from Fish Oil

While this article focuses on fish oil, it's worth briefly addressing the comparison since both are frequently used together in performance and longevity protocols. Creatine monohydrate primarily supports phosphocreatine resynthesis in skeletal muscle and has emerging evidence in cognitive support, particularly under sleep deprivation (Dolan et al., Nutrients 2019; PMID: 31878026). Fish oil's mechanisms are largely anti-inflammatory, membrane-structural, and eicosanoid-modulating — a different but complementary profile.

Ones formulas can include both when user data (training load from wearables, inflammatory markers from bloodwork) indicates that both would be clinically appropriate.

---

How Ones Addresses This: Building Your Omega-3 Protocol From Data

Most supplement companies sell you a fixed-dose fish oil capsule calibrated for the average person. Ones takes a different approach: your Omega-3 recommendation is driven by your actual Omega-3 Index from blood work, your inflammatory marker profile (hs-CRP, triglycerides), and your wearable-derived recovery data — not a population average.

Key Ones ingredients relevant to this article:

IngredientClinical Dose in OnesEvidence Base
Omega-3 (EPA+DHA)Calibrated to your Omega-3 Index target (typically 8–12%)REDUCE-IT (Bhatt et al., 2019); Yurko-Mauro et al. (2010)
Magnesium ComplexGlycinate-dominant blend, dosed to clinical repletion rangeRosanoff et al. (2012); NIH ODS magnesium monograph
CoQ10/Ubiquinol200 mg ubiquinol (superior bioavailability form)Mortensen et al., *JACC Heart Failure* 2014

Ones' AI health practitioner cross-references your blood panel, health history, and goals against 70+ clinical-grade ingredients to build a custom capsule formula — available in 6, 9, or 12-capsule daily plans. Rather than guessing whether you need 1 g or 4 g of EPA+DHA, your formula reflects what your biomarkers actually indicate.

Unlike platforms like Ritual (which offers fixed-formula multivitamins) or Thorne (which provides practitioner-grade individual supplements without AI personalization), Ones builds a formula where the dose of every ingredient is calibrated to your specific data — including fish oil. If you want to understand the omega-3 EPA to DHA ratio that best fits your goals, that nuance is built into the Ones recommendation engine.

---

Key Takeaways

  • Fish oil's primary active compounds are EPA and DHA — not ALA — and they work through membrane integration, eicosanoid competition, and specialized pro-resolving mediator synthesis.
  • Triglyceride reduction is the most consistently proven cardiovascular effect, with meaningful reductions at 2–4 g/day EPA+DHA; hard cardiovascular event data depend heavily on dose and EPA purity.
  • Brain health benefits are significant: 900 mg/day DHA improved memory in older adults over 24 weeks; EPA-dominant formulas show antidepressant effects in meta-analyses.
  • Joint and inflammatory benefits emerge after 12+ weeks at 2.7–9 g/day EPA+DHA, with reduced NSAID dependence documented in RA populations.
  • Take fish oil with a fat-containing meal to maximize bioavailability by up to 73%; split high doses across two meals for tolerability.
  • Precision dosing matters: the difference between 1 g and 4 g/day is not trivial — platforms like Ones use your actual Omega-3 Index and inflammatory markers to calibrate your dose rather than defaulting to a population average.

---

This article is for informational purposes only and does not constitute medical advice. Consult a qualified healthcare provider before beginning any new supplement protocol, particularly if you take anticoagulant medications, as high-dose fish oil may affect platelet aggregation.

Written by Jared Murray, Co-Founder & Head of Health Research, Ones.

Jared is the co-founder and head of health research at Ones, with 25 years applying nutrition science, biomarker interpretation, and clinical supplementation research to individual health programs. He leads the editorial process for the Ones Health Library, where lab data, wearable biometrics, and peer-reviewed clinical research are translated into evidence-based, personalized supplement guidance.

Disclosure: Ones formulates and sells personalized supplements that may include ingredients discussed in this article. We have a financial interest in the products mentioned. Recommendations are based on published research and our editorial standards, not sales targets.

This article is educational content, not medical advice. Consult a healthcare provider before changing your supplement regimen.

Further reading

Related reading